The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
Abstract
High cholesterol is a major risk factor for cardiovascular disease 1. Currently, no drug lowers cholesterol through directly promoting cholesterol excretion. Human genetic studies have identified that the loss-of-function Asialoglycoprotein receptor 1 (ASGR1) variants associate with low cholesterol and a reduced risk of cardiovascular disease 2. ASGR1 is exclusively expressed in liver and mediates internalization and lysosomal degradation of blood asialoglycoproteins 3. The mechanism by which ASGR1 affects cholesterol metabolism is unknown. Here, we find that Asgr1 deficiency decreases lipid levels in serum and liver by stabilizing LXRα. LXRα upregulates ABCA1 and ABCG5/G8, which promotes cholesterol transport to high-density lipoprotein and excretion to bile and faeces 4, respectively. ASGR1 deficiency blocks endocytosis and lysosomal degradation of glycoproteins, reduces amino-acid levels in lysosomes, and thereby inhibits mTORC1 and activates AMPK. On one hand, AMPK increases LXRα by decreasing its ubiquitin ligases BRCA1/BARD1. On the other hand, AMPK suppresses SREBP1 that controls lipogenesis. Anti-ASGR1 neutralizing antibody lowers lipid levels by increasing cholesterol excretion, and shows synergistic beneficial effects with atorvastatin or ezetimibe, two widely used hypocholesterolaemic drugs. In summary, this study demonstrates that targeting ASGR1 upregulates LXRα, ABCA1 and ABCG5/G8, inhibits SREBP1 and lipogenesis, and therefore promotes cholesterol excretion and decreases lipid levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this was recently contended by a study reporting Asgr1 deficiency in mice has no effect on hepatic LDLR abundance [88].Instead, this study suggests that reduced plasma LDL-cholesterol in the absence of Asgr1 is due to increased LXRα signaling and enhanced reverse cholesterol efflux.”
From The low-density lipoprotein receptor: Emerging post-transcriptional regulatory mechanisms (2025) · cites this paper as [88]
In the citing paper
“The LDLR peptide has an N-terminal ligand binding domain which has high affinity for Apolipoprotein E74,75, as well as Apolipoprotein B (ApoB)76, the main structural components of VLDL/LDL.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [75]
In the citing paper
“These glycosylation sites not only impact LDLR stability and function, but may also affect degradation rates of the LDLR, specifically by ASGR1 (discussed in more detail below), an E3 ligase which recognizes a glycosylated region of LDLR75.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [75]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mechanisms and regulation of cholesterol homeostasis
Luo, J., Yang, H., & Song, B.-L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0190-7 · Cited by 1,980
Self-citationCarbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,840
Self-citationBerge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
Termination of autophagy and reformation of lysosomes regulated by mTOR
Yu, L., McPhee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, F., et al. (2010) · Nature · doi:10.1038/nature09076 · Cited by 1,544
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,293
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Wang, S., Tsun, Z.-Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W. C., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 865
Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. H., & Mangelsdorf, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109927200 · Cited by 852
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797
Cited by
Sorted by citations
Items 101–190 of 190
Wang, Y., Zhang, L., Fan, M., Hou, X., Li, X., Zhang, W., Liu, W., Li, Y., Lu, Y., Li, F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71388-x · Cited by 4
Self-citationA High-Throughput Cell-Based Luciferase Reporter Assay for Identifying Inhibitors of ASGR1
Gan, L., Zou, H., Yang, Z., Wang, J., Sheng, Y., Du, P., Zhang, S., & Feng, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104590 · Cited by 4
Self-citationA novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway
Huang, Y. H., Ran, X., Liu, H., Luo, M., Qin, Y., Yan, J., Li, X., & Jia, Y. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00758-0 · Cited by 4
ASGR1 is a promising target for lipid reduction in pigs with PON2 as its inhibitor
Yin, Y., Liu, J., Yu, J., Dong, D., Gao, F., Yu, L., Du, X., & Wu, S. (2024) · iScience · doi:10.1016/j.isci.2024.110288 · Cited by 4
Xin, Z., Chen, H., Xu, J., Zhang, H., Peng, Y., Ren, J. F., Guo, Q., Song, J., Jiao, L., You, L., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16677 · Cited by 4
Lu, X. Y., Guo, R., Wang, M., Sun, L., Song, Z., Zhang, Z., Wang, B., & Zhang, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163523 · Cited by 3
Self-citationA BODIPY-tagged trivalent glycocluster for receptor-targeting fluorescence imaging of live cells
Guo, C., Si, F.-Y., Wang, C.-H., Wang, N., Hu, X., James, T. D., Li, J., Wang, C., & He, X. (2025) · Chemical Science · doi:10.1039/d4sc08472a · Cited by 3
Yu, B., Li, J., Yu, Y., Sun, Y., Wang, Y., Wang, B., Tan, X. W., Lu, Y., Wang, N., & Liu, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70064 · Cited by 3
Strategies for targeted protein degradation through lysosomal pathways
Wang, W. P., Fang, Y., & Sheng, C. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115837 · Cited by 3
Gao, Y., Gong, Y., Du, Z., Zhang, W., Lai, L., Lan, M., Jia, Z., Song, X., Xiong, Y., Gong, Y., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158584 · Cited by 3
Self-citationScavenger receptors: An auspicious therapeutic target for autoimmune diseases
Liu, Y.-K., Hao, M., Yang, F., Jing, K.-X., Zhao, S., Wu, C., & Pan, H. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110546 · Cited by 3
Self-citationXu, L., Sun, M., Qi, H., Ju, C., Chen, Z., Gao, X., & Lin, Z. (2022) · Metabolites · doi:10.3390/metabo12121276 · Cited by 3
Cholesterol metabolism in T‐cell aging: Accomplices or victims
Hu, C., Wu, H., Zhu, Q., Cao, N., & Wang, H. (2023) · The FASEB Journal · doi:10.1096/fj.202300515r · Cited by 3
Gong, J., Duan, X., Xiang, B., Qin, L., & Hu, J. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103968 · Cited by 3
Dong, K., Zhang, Y., Liu, Y., Li, G., Lou, H., Wang, K., Wang, L., & Peng, X.-P. (2025) · Organic Letters · doi:10.1021/acs.orglett.4c04789 · Cited by 3
Self-citationZannad, F. M., & Ferreira, J. P. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae399 · Cited by 3
Zhu, H., Zhong, Z., Zhao, G., Cao, Y., Liu, W., Guo, Y., & Jin, J. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s511208 · Cited by 2
ASGR1 inhibitors, inflammation, and heart failure: A Mendelian randomization analysis
Ye, X., Yang, M., Hong, Y., Lin, Z., Peng, J., & He, L. (2025) · Lipids · doi:10.1002/lipd.12446 · Cited by 2
Shi, J., Li, Q., Li, J., Bai, J., Xi, J., He, Q., Zhou, J., Wang, X., Song, X., Li, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202510275 · Cited by 2
Ren, H., Zhao, T., Lv, Z., Xie, G., & Sun, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103997 · Cited by 2
Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study
Sullivan, V. K., Chen, J., Appel, L. J., Schrauben, S. J., Ricardo, A. C., Rao, P. S., Dobre, M. A., Pradhan, N., Chen, J., He, J., et al. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000941 · Cited by 3
The ubiquitin system in heart and vessel pathobiology: From mechanisms to therapeutic strategies
Zhu, J., Qiu, Z., Xu, Y., Guo, Q., Yang, S., Zhao, Y., & Shi, B. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2025.102023 · Cited by 2
Self-citationHuang, Z., Tan, P., Gu, B., Liu, S., Li, H., Chen, J., Ren, B., Sun, L., WEN, J., Li, Y., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00409-4 · Cited by 2
Self-citationDu, M., Ye, L., Wang, C., Jiang, T., & Liu, F. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107194 · Cited by 2
Zhang, Z., Chen, X., Hu, X., Liang, J., Huang, H., Lu, W., Zhu, M., Fang, M., Yin, L., Li, W., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04181-z · Cited by 2
Ciaula, A. D., Khalil, M., Garruti, G., & Portincasa, P. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101056 · Cited by 2
Zhang, M., Li, J., Ji, N., Bao, Q., Sun, N., Rong, H., Xu, P., Yang, L., Xie, M., He, S., et al. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c03569 · Cited by 2
Self-citationAnalysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study
Gao, D., Wei, X., Yang, Y., Li, L., Qi, Y., Zhang, R., Yuan, Z., Du, R., Sun, X., Yin, H., et al. (2023) · Informatics and Health · doi:10.1016/j.infoh.2023.08.001 · Cited by 2
Self-citationForsythoside B and Its Derivatives as Novel ASGR1 Inhibitors for Enhanced Cholesterol Efflux
Ma, M., Liu, R., Liu, Y., Xu, P., Guo, Y., He, Z., Zhang, Z., Wang, K., & Wang, L. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202501119 · Cited by 2
Self-citationMembrane contact sites orchestrate cholesterol homeostasis that is central to vascular aging
Li, W., Pang, Y., Jin, K., Wang, Y., Wu, Y., Luo, J., Xu, W., Zhang, X., Xu, R., Wang, T., et al. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1612 · Cited by 1
Self-citationLi, Q., Mei, C., Xing, D., Liu, F., Zhou, D., & Zou, Y. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107868 · Cited by 1
Liu, Y., Pan, D., Zhang, P., Shao, Y., Kong, Y., Jiang, Z., Zhu, W., Wang, H., Liu, X., Qian, S., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110231 · Cited by 1
Self-citationRole and mechanism of ASGR1 in acute liver injury
Huang, L., Wang, Y., Li, D., Gao, G., Wu, H., Zeng, Y., Zhang, S., Chen, Z., Guo, R., & Chen, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124157 · Cited by 1
Liu, X., Xie, R., Cai, Y., Lan, H., Mu, J., Zhang, C., & Li, B. (2026) · Reproductive Sciences · doi:10.1007/s43032-025-02039-7 · Cited by 1
Wang, J.-M., Jiang, L.-Y., Deng, Y.-T., Li, J.-Y., Sun, H., Ran, L., & Xiao, X. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005638 · Cited by 1
Self-citationHan, N., Tian, X., Shen, Z., Wang, L., Zhu, H., Zhao, Y., & Yang, X. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c11794 · Cited by 1
Wang, S., Zhang, Q., Lu, H., Yu, M., Alagawany, M. M., Chen, C., & Zhou, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1746365 · Cited by 1
Proteogenomic Analysis of Coronary Artery Calcification in Human Populations
El-Sabawi, B. R., Huang, X., Lin, P., Anwar, M. Y., Betti, M. J., Kim, N., Perry, A., Perera, B. L. A., Gajjar, P., Colangelo, L. A., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.324171 · Cited by 1
In vivo base editing of Asgr1 reduces blood lipids in mice
Agrahari, G., Nguyen, N. T. K., Li, M., Zhang, C., Xu, J., Zhang, J., Chen, Y. E., & Han, R. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.020 · Cited by 1
The asialoglycoprotein receptor 1 (ASGR1): emerging new roles in health and disease
Geremew, D., Tan, J. T. M., Psaltis, P. J., & Bursill, C. A. (2026) · Biomarker Research · doi:10.1186/s40364-026-00954-8 · Cited by 1
Khan, I., Meenakshi, S., Abubakar, M., Kumar, N., Gaikwad, V. L., Rai, A., & Murti, K. (2026) · Endocrine · doi:10.1007/s12020-026-04686-5 · Cited by 1
Hou, Y., Luo, Y., Chen, J., Shang, X., Chang, Y., Zhang, X., Ding, Y., Zhao, W., Ding, C., Feng, X., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.036 · Cited by 1
Mechanisms and therapeutic potential of AMPK signaling pathway in the regulation of lipid metabolism
Gong, X., Dai, X., Liu, X., Zhao, J., & Sun, Y. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12516-0 · Cited by 1
Zhu, H., Huang, X., You, K., Chen, Y., Li, P., Tao, J., Yu, X., Jie-Hui, X., Xu, G., & Li, Y. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70496 · Cited by 1
Self-citationTinworth, A. C., Yao, P., Iona, A., Pozarickij, A., Ende, A. V., Millwood, I. Y., Walters, R. G., Clarke, R., Bragg, F., & Chen, Z. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00871-x · Cited by 1
Thng, Y., Kua, J. E. H., Chua, W., Foo, D. C. G., & Jafary, F. H. (2011) · Circulation
Hou, Y., Dai, H., Chen, N., Zhao, Z., Wang, Q., Hou, T., Zheng, J., Wang, T., Li, M., Lin, H., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad466
Self-citationAdding a New Piece to the ASGR1 Puzzle: ANGPTL3
García‐Arcos, I. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321882
ENCODE guided WGS analysis can identify trait associated regulatory regions driven by rare variants
Flanagan, J. T., Nam, K., & Lee, S. (2026) · BMC Genomics · doi:10.1101/2024.11.06.24316407
Li, M., Wang, R., Yan, T., Tao, X., Gao, S., Wang, Z., Chai, Y., Qiu, S., & Chen, W. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17391
Lai, M., & Ye, X. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03208-9
Research progress of cholesterol modification
Liu, Q., & Song, B. (2024) · Scientia Sinica Chimica · doi:10.1360/ssc-2024-0224
Self-citationWei, L., Wang, F., Hua, L., Wang, Q., Hu, B., Yang, Z., Li, L., Liu, C., & Wang, K. (2025) · Biology · doi:10.3390/biology14060712
Self-citationTissue specific role of ABCA1 in lung cholesterol homeostasis under high-cholesterol diet
Ma, J., Gong, Z., Lü, H., Yang, H., Wang, S., Zhu, Q., Liu, H., Li, Y., Zhang, Y., & Lian, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1649407
Self-citationA partner switch from CDS2 to RAB1A redirects MBOAT7 to inhibit DGAT2-mediated lipid droplet growthPreprint
Xu, J., Zhang, J., Wang, W., Su, H., Chen, S., Ding, M., & Huang, X. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.26.672501
PRKAG1 mediates the anti-Japanese encephalitis virus effect of Nitazoxanide through autophagy
Ma, H., Wang, X., Wang, C., Ye, W., Zhou, W. H., Zou, F., & Zhang, K. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110740
Svecla, M., Da Dalt, L., Moregola, A., Nour, J., Baragetti, A., Uboldi, P., Donetti, E., Arnaboldi, L., Beretta, G., Bonacina, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26673696
Zhang, J. (2025) · eCommons (Cornell University) · doi:10.7298/egg3-qe59
Huang, Y., Ran, X., Liu, H., Luo, M., Qin, Y., Yan, J., Li, X., & Jia, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23529014
Svecla, M., Da Dalt, L., Moregola, A., Nour, J., Baragetti, A., Uboldi, P., Donetti, E., Arnaboldi, L., Beretta, G., Bonacina, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26673699
Roa Colomo, A. (2024) · Institutional Repository of the University of Granada (University of Granada)
Endosomal trafficking complexes in the regulation of liver metabolism
Motzler, K. F., Herzig, S., & München, T. U. (2023)
Transcriptomic Profiling of Depression : Mitochondrial, Metabolic, and Immune Pathway Dysregulation
Tronde, S. (2025) · Publications (Mid Sweden University)
Xie, F., Chang, X., Wang, Q., Zhan, Q., Jin, P., Zheng, Y., & Wu, Z. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105619
LXR activation in skeletal muscle cells enhances differentiation and promotes protein synthesis
Takase, H., Chikazawa, M., Noguchi, M., Ichi, I., Takahashi, Y., Yamauchi, Y., Shimizu, M., Sato, R., & Sasaki, T. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00261.2025
Yu, X., Bao, J., Liu, Y., Yuan, B., Ma, Q., Li, S., & Hu, F. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9250989
Self-citationShi, R., Wang, F., Li, C., Xiao, C., Bai, C., Chen, A. F., & Yang, W. (2026) · Clinical Science · doi:10.1042/cs20250290
Wang, Y., Han, X., Chen, J., Xiang, Y., Mao, W., Zhang, X., Chen, Y., Zhan, J., & Liu, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-9376900/v1
Derrick, J. T., Moll, T. O. C., Sweeney, D. W., Shin, J., Svecla, M., Norata, G. D., & Farber, S. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113239
Liu, X., Shi, J., & Wang, T. (2026) · Reproduction · doi:10.1093/reprod/xaag073
Yang, H., Cui, X., Yu, K., Zhao, Z., Jin, L., Wang, Q., Yang, H., Li, X., Gao, X. Z., & Wu, X. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215027
Li, W., Ma, X., Xia, J., Qi, Y., Zhao, X., Ge, P., Sheng, J., Wei, J., Ma, Y., Yuan, Y., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158475
Self-citationSuccinylation-annotated genes in AMI: multi-omics and single-cell prioritization of ASGR2 and NPL
Yu, J., Xu, M., Fang, J., Liu, Y., Wang, C., Shi, S., Wang, K., 李运伦, & Zhang, L. J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1836786
Self-citationProteomic profiling reveals novel insights into hypercortisolism adrenal adenomas
Shi, X., Yang, Y. S., He, C., Xiong, Y., Zhang, W., Du, M., Chen, Z., Yin, J., Liu, Y., Qi, S., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156691
Self-citationWang, Y., Zhao, L., Guo, S., Shi, Y., Yue, Z., Han, X., Tang, X., Yao, G., Chen, W., & Sun, L. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05167-2
Driving cholesterol down and out: In vivo ASGR1 base editing
Dong, L.-W., & Song, B. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.009
Self-citationDNA methylation informs adult cardiovascular risk and prevention for low birthweight individuals
Tang, J. Y., Ng, N. Y. T., Kwok, A. W. S., Mak, C. C. Y., Cheung, Y., & Chung, B. H. Y. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04242
Zhang, C.-Y., Ding, J., Sun, Y.-J., Zhong, W., Yang, N.-S.-Y., Li, P.-Z., Jia-Hui, Z., Yang, J.-T., Liang, L.-Y., Zhou, Y., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156747
Cell-specific cPGES control of glucocorticoid receptor function drives MASLD progression
Zhong, D., Qiao, R., Quan, G., Song, C., Fu, K., Zou, Y., Qi, X., Su, W., Liu, Y., Li, F., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117901
Self-citationKumar, S., Aceves, M., Guerra, L., Granados, J., Novilla, E., Juarez, F., Oluwadairo, T., Leandro, A. C., Leandro, M., Peralta, J. M., et al. (2026) · Cells · doi:10.3390/cells15171592
Zeng, X., Nie, Y., Zhang, Z., Quan, Y., Ye, G., Deng, P., & Leng, Y. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134762
Increased risk of gallstones with obesity and rapid weight loss
Khalil, M., Ciaula, A. D., Baffy, G., Krawczyk, M. J., & Portincasa, P. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102142
Zaufel, A., Sun, W., Pastore, N., Taschler, U., Wagner, C., Hackl, H., Sommer, J., Silbert-Wagner, D., Hengstler, J. G., Begher‐Tibbe, B., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee1905
Zhao, T., Yu, Y., Wang, Y., Zhang, L., Xiao, J., Chen, S., & Li, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1974149
Lu, Z., Mao, T., Chai, L., Chen, K., Liu, K., Zhang, C., & Kou, H. (2026) · Phytotherapy Research · doi:10.1002/ptr.70493
Metadata
- Authors
- Wang, J.-Q., Li, L.-L., Hu, A., Deng, G., Wei, J., Li, Y.-F., Liu, Y.-B., Lu, X.-Y., Qiu, Z.-P., Shi, X.-J., Zhao, X., Luo, J., & Song, B.-L.
- Affiliations
- Wuhan University (CN)
- Corresponding author
- Song, Bao-Liang
- ORCID
- Venue
- Nature
- Published
- 2022-08-03
- Volume
- 608
- Issue
- 7922
- Pages
- 413-420
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W4289638327
- Semantic Scholar
- 2c228e8e3bb08f6cb71f8c0237f1ccbab6eb5db0
- Cited by
- 188
- References
- 39
- Citations by year
- 2026: 51 · 2025: 53 · 2024: 45 · 2023: 31 · 2022: 7
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- ASGR1, asialoglycoprotein receptor, cholesterol excretion, hypercholesterolemia, liver X receptor alpha, ABCA1, ABCG5/G8, SREBP1, lipogenesis, AMPK, mTORC1, lysosomal degradation, endocytosis, high-density lipoprotein, cardiovascular disease, neutralizing antibodies, ezetimibe, atorvastatin
- MeSH terms
- Atorvastatin, Ezetimibe, ATP Binding Cassette Transporter, Subfamily G, Member 5, ATP Binding Cassette Transporter, Subfamily G, Member 8, Liver X Receptors, Mechanistic Target of Rapamycin Complex 1, Asialoglycoproteins, Cardiovascular Diseases, Cholesterol, Drug Synergism, Endocytosis, Humans, Lipids, Liver, Lysosomes, BRCA1 Protein, Asialoglycoprotein Receptor, Ubiquitin-Protein Ligases, Lipid Metabolism, Sterol Regulatory Element Binding Protein 1, AMP-Activated Protein Kinases, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
